Exhibit 99.3
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Shares, without par value, of Edesa Biotech, Inc., a British Columbia corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Velan Capital Master Fund LP |
|
By: | /s/ Adam Morgan | |
| Adam Morgan, Managing Member of Velan Capital Holdings LLC, its General Partner |
Date: | 02/18/2025 |
Velan Horizon Fund LP |
|
By: | /s/ Adam Morgan | |
| Adam Morgan, Managing Member of Velan Horizon GP LLC, its General Partner |
Date: | 02/18/2025 |
Velan Capital Opportunity Fund II LLC |
|
By: | /s/ Adam Morgan | |
| Adam Morgan, Managing Member of Velan Capital Holdings LLC, its Managing Member |
Velan Horizon GP LLC |
|
By: | /s/ Adam Morgan | |
| Adam Morgan, Managing Member |
Date: | 02/18/2025 |
Velan Capital Holdings LLC |
|
By: | /s/ Adam Morgan | |
| Adam Morgan, Managing Member |
Date: | 02/18/2025 |
Velan Capital Investment Management LP |
|
By: | /s/ Adam Morgan | |
| Adam Morgan, Managing Member of Velan Capital Management LLC, its General Partner |
Date: | 02/18/2025 |
Velan Capital Management LLC |
|
By: | /s/ Adam Morgan | |
| Adam Morgan, Managing Member |
Date: | 02/18/2025 |
Morgan Adam |
|
By: | /s/ Adam Morgan | |
| Adam Morgan |
Date: | 02/18/2025 |
VENKATARAMAN BALAJI |
|
By: | /s/ Balaji Venkataraman | |
| Balaji Venkataraman |
Date: | 02/18/2025 |